Patients with traumatic brain injury (TBI) are at risk for development of thromboembolic disease. The use of chemoprophylaxis in this patient group has not fully been characterized. The authors hypothesize that early chemoprophylaxis in patients with TBI is safe and efficacious.
In May 2009, a protocol was instituted for patients with TBI where chemoprophylaxis for thromboembolic disease (either 30 mg of Lovenox twice daily or 5000 U of heparin 3 times a day) was initiated 24 hours after an intracranial hemorrhage (ICH) was demonstrated as stable on head CT image. Two cohorts were evaluated: Cohort A included patients from May 2008 through April 2009 who had no routine administration of chemoprophylaxis, and Cohort B included patients from May 2009 through May 2010 after the protocol was instituted. The groups were compared, with the major outcomes being deep venous thrombosis (DVT), pulmonary embolism, and increase in size of ICH.
Of the 312 patients with TBI who were seen during the study course, 236 patients met criteria for inclusion in the study: 107 patients in Cohort A and 129 patients in Cohort B. The DVT rate was 6 occurrences (5.61%) in Cohort A and 0 occurrences (0%) in Cohort B, which was a statistically significant difference (p = 0.0080). Pulmonary embolism was found in 4 patients (3.74%) in Cohort A and 1 patient (0.78%) in Cohort B, a difference that did not reach statistical significance (p = 0.18). Three instances (2.8%) in Cohort A and 1 instance (0.7%) in Cohort B of increased ICH occurred after starting anticoagulation for chemoprophylaxis; this was not statistically different (p = 0.33).
Use of chemoprophylaxis in TBI 24 hours after stable head CT is safe and decreases the rate of DVT formation.
Abbreviations used in this paper:AIS = Abbreviated Injury Scale; DVT = deep vein thrombosis; GCS = Glasgow Coma Scale; ICH = intracranial hemorrhage; ISS = Injury Severity Score; LOS = length of stay; PE = pulmonary embolism; TBI = traumatic brain injury; VTE = venous thromboembolism.
Address correspondence to: N. Scott Litofsky, M.D., Division of Neurological Surgery, University of Missouri-Columbia School of Medicine, One Hospital Dr., MC 321, Columbia, MO 65212. email: email@example.com.
Please include this information when citing this paper: published online September 20, 2013; DOI: 10.3171/2013.8.JNS13424.
CageTALambornKRWareMLFrankfurtAChakalianLBergerMS: Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol93:151–1562009
DudleyRRAzizIBonniciASalujaRSLamoureuxJKalmovitchB: Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits. J Neurotrauma27:2165–21722010
FarahvarAGerberLMChiuYLCarneyNHärtlRGhajarJ: Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring. Clinical article. J Neurosurg117:729–7342012
KurtogluMYanarHBilselYGulogluRKizilirmakSBuyukkurtD: Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg28:807–8112004
KwiattMEPatelMSRossSELachantMTMacNewHGOchsnerMG: Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study. J Trauma Acute Care Surg73:625–6282012
MinshallCTErikssonEALeonSMDobenARMcKinzieBPFakhrySM: Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2. J Trauma71:396–4002011
NorwoodSHMcAuleyCEBerneJDVallinaVLKernsDBGrahmTW: Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg137:696–7022002
O'CarrollCBCapampanganDJAguilarMIBravoTPHoffman-SnyderCRWingerchukDM: What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic. Neurologist17:232–2352011
ReiffDAHaricharanRNBullingtonNMGriffinRLMcGwinGJrRueLWIII: Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma66:1436–14402009
SaadehYGohilKBillCSmithCMorrisonCMosherB: Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT. J Trauma Acute Care Surg73:426–4302012